Table 1.
Age | 71.9 (11.8) (46–87) |
Sex | |
Male | 16 (53.3%) |
Female | 14 (46.6%) |
Diagnosis | |
Basal cell carcinoma | 17 (56.6%) |
Squamous cell carcinoma | 10 (33.3%) |
Merckel cell carcinoma | 1 (3.3%) |
Mucinous carcinoma | 1 (3.3%) |
Sebaceous carcinoma | 1 (3.3% |
Location | |
Head and neck | 25 (83.3%) |
Cheek | 9 (30.0%) |
Nose | 8 (26.6%) |
Forehead | 2 (6.6%) |
Neck | 2 (6.6%) |
Temple | 1 (3.3%) |
Scalp | 1 (3.3%) |
Mastoid area | 1 (3.3%) |
Upper eyelid | 1 (3.3%) |
Extremities | 3 (10.0%) |
Index finger | 1 (3.3%) |
Lower leg | 1 (3.3%) |
Sole | 1 (3.3%) |
Trunk | 2 (6.6%) |
Suprapubic area | 1 (3.3%) |
Buttock | 1 (3.3%) |